Purchase Order 75F40122P00016
Award Date 1/25/22
Potential Completion Date 2/6/25
Potential Value $120K
Federal Agency
Awardee
Ultimate Awardee
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Silver Spring, MD 20993, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Food and Drug Administration awarded a $120,290.40 firm fixed price purchase order to Bruker Biospin Corp for a Cryoprobe/Cryoplatform System Service Agreement. The contract, which was not set aside for small businesses, was awarded on July 11, 2023, with an ultimate completion date of September 24, 2026. Work will be performed at Bruker Biospin Corp's facility in Billerica, Massachusetts. Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, specializes in the design, manufacture, and...
- This is a firm fixed-price purchase order awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a for-profit manufacturer of scientific instruments, in the amount of $238,161.00. The contract is for the delivery of a cryogenically-cooled 13C direct detect probe and 3 years of preventative maintenance for an existing Bruker nuclear magnetic resonance (NMR) spectrometry system. There was no set-aside designation for this award. The original...
- The U.S. Food and Drug Administration (FDA) awarded a $195,933.11 firm-fixed-price purchase order to Bruker Biospin Corp, a subsidiary of Bruker Scientific LLC, to acquire a comprehensive service agreement from the original equipment manufacturer (OEM) Bruker. The agreement includes preventive maintenance with two (2) helium refills per year, as well as any repairs and support for a Bruker Avance III HD 600 instrument. The award has an ultimate completion date of August 31, 2027. Bruker...
- Bruker Biospin Corp, a manufacturer of scientific instruments and subsidiary of Bruker Corporation, has been awarded a firm fixed price purchase order totaling $210,321.52 by the Department of Health and Human Services' Food and Drug Administration. The contract is for preventative maintenance and repair services for a Bruker Avance III 600 MHz nuclear magnetic resonance spectrometer located in Jamaica, New York through December 18, 2022. No set-aside designation was used for this award to...
- This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Bruker Biospin Corp, a manufacturer of scientific instruments and equipment, for the delivery of a Cryo Probe for Nuclear Magnetic Resonance (NMR) analysis. The contract has a potential value of $187,725.00 and a completion date of December 31, 2020. Bruker Biospin Corp is a subsidiary of Bruker Corporation, which provides specialized equipment, maintenance, and support...
- The Department of Health and Human Services Food and Drug Administration awarded a $126,772 firm fixed price purchase order to Bruker Biospin Corp. to deliver a solid-state NMR probe. The place of performance is in Billerica, Massachusetts, with work expected to be completed by April 2024. Per the solicitation, the FDA requested quotes for a solid-state NMR probe to add to an existing 500-MHz instrument in order to expand its analytical capabilities. As the leading regulatory agency for ensuring...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Bruker Biospin Corp for a preventive maintenance and repair service agreement for cryo-cooler components of Bruker BioSpin 47/40 systems. Valued at two hundred fourteen thousand one hundred eighty-five dollars, this contract supports maintenance of cryogenic cooling equipment through August 2028 without a set-aside designation. As a manufacturer of scientific instruments,...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp. a $21,810 purchase order to provide helium fill maintenance services for a 600 MHz nuclear magnetic resonance spectrometer located in Billerica, Massachusetts. As the prime contractor, Bruker Biospin will perform the requested maintenance through December 2024 on the equipment, which is used to support the FDA's regulatory and research efforts. No subcontractors or set aside designations were...
- The Department of Health and Human Services Food and Drug Administration awarded Bruker Biospin Corp, a subsidiary of Bruker Corporation, a $110,097.30 firm-fixed-price purchase order to provide an automatic sample changer and compatible probe for a Bruker 400 MHz nuclear magnetic resonance (NMR) spectrometer. The award has an August 17, 2024 completion date and was made on September 16, 2022. Bruker Biospin Corp is a for-profit manufacturer of scientific instruments and equipment. The company...
- This federal contract award was issued by the Food and Drug Administration (FDA) to Bruker Biospin Corp, a subsidiary of Bruker Corporation, for the procurement of a Quadruple Resonance Inverse (QCI) Detection Cryoprobe for high-field nuclear magnetic resonance (NMR) instrumentation. The contract, valued at $315,583.00, was awarded on a firm fixed-price basis without any set-aside designation. The award supports the FDA's 850 MHz Instrument Cryoprobe program, which focuses on advanced analytical...